{"schema_version":"secwatch.filing_event.v1","accession":"0000950170-22-026395","form_type":"8-K","ticker":"HYPR","cik":"0001833769","company_name":"Hyperfine, Inc.","filed_at":"2022-12-12T23:59:59+00:00","discovered_at":"2026-05-14T18:03:52.535634+00:00","generated_at":"2026-06-21T06:20:11.835146+00:00","sec_items":["2.05"],"event_type":"other_material","sentiment":"negative","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"Hyperfine cuts ~13% of workforce; expects up to $1.7M in restructuring costs","bullets":["Terminated approximately 13% of global workforce, including employees of subsidiary Liminal Sciences.","Estimated restructuring costs of up to $1.7M, mainly cash severance and fixed asset impairment.","Restructuring expected to be substantially complete in Q4 2022 and Q1 2023.","Actions aimed at reducing costs and streamlining operations."],"urls":{"canonical":"https://secwatch.observer/filing/0000950170-22-026395","json":"https://secwatch.observer/filing/0000950170-22-026395.json","markdown":"https://secwatch.observer/filing/0000950170-22-026395.md","text":"https://secwatch.observer/filing/0000950170-22-026395.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1833769/000095017022026395/0000950170-22-026395-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1833769/000095017022026395/hypr-20221206.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-21T06:20:11.835146+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"5a56701830958bbd2af429a100c3af0ff908e735","claim":"Hyperfine, Inc. announced a restructuring with charges of up to $1.7 million affecting global workforce, including subsidiary Liminal Sciences, Inc. (approximately 13% of its global workforce).","evidence_excerpt":"On December 6, 2022, Hyperfine, Inc. (the “Company”) committed to an organizational restructuring designed to decrease its costs and create a more streamlined organization to support its business. As a result, the Company has terminated approximately 13% of its global workforce including, among others, the employees of its subsidiary, Liminal Sciences, Inc. In connection with the restructuring, the Company currently estimates it will incur up to $1.7 million of costs, consisting primarily of cash severance costs, other severance benefits, fixed asset impairment costs and other related restructuring costs.","evidence_source":"SEC 8-K Item 2.05/2.06","evidence_url":"https://www.sec.gov/Archives/edgar/data/1833769/000095017022026395/0000950170-22-026395-index.htm","confidence":0.9,"family_label":"Restructurings & Charges","details":[{"label":"Type","value":"restructuring"},{"label":"Charge","value":"up to $1.7 million"},{"label":"Affected area","value":"global workforce, including subsidiary Liminal Sciences, Inc."},{"label":"Headcount","value":"approximately 13% of its global workforce"}],"fact_type":"restructuring_charge"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}